THE ORIGINAL / 2019-06-06

Purple Soothing Conditioning Essence

UG/2019/51173A-01 · 3 complete pages, read here

Reports provided by the ESAKI Hong Kong general distributor.

2019-06-0618 test entriesSample and date details ↓
Historical submitted sample; similar names do not establish current formulation, shade or batch equivalence.
Not detected means below the stated quantification/detection limit, not absolute zero, efficacy or freedom from allergy.
DOCUMENT / UG/2019/51173A-01

Every page. In context.

Read the text summary ↓

All original pages and margins are retained. Use the zoom controls for small print, then scroll across or down to read.

UG/2019/51173A-01 · Page 1 / 3
UG/2019/51173A-01 complete original page 1 / 3
UG/2019/51173A-01 · Page 2 / 3
UG/2019/51173A-01 complete original page 2 / 3
UG/2019/51173A-01 · Page 3 / 3
UG/2019/51173A-01 complete original page 3 / 3

Complete report · 3 pages

These are complete-page renderings of the original, not a reissued certificate. English text is an explanatory summary; the laboratory document keeps its original language.

Specific to this sample.

Report number
UG/2019/51173A-01
Report date
2019-06-06
Sample name (translated)
Purple Soothing Conditioning Essence
Laboratory
SGS Taiwan Ltd.
Sample batch
Not stated in the original
Received
2019-05-23
Manufactured
2019-04-23
Sample expiry
2021-04-23
Test period
2019-05-23 → 2019-06-06
Sample specification / original notation
120 mL (package label in the original final-page sample photograph; not a separately stated total received quantity)
Complete page count
3 pages, in original order

Individual results and limits

18 entries; interpret every value with its sample, method and unit.

1. Estriol

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

2. Estradiol

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

3. Estrone

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

4. Ethinyl estradiol

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

5. Estradiol benzoate

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

6. Diethylstilbestrol

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

7. Pregnanediol

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 1 mg/kg · LOQ

8. Progesterone

Method: LC/MS/MS; TFDA suggested cosmetic estrogen method

N.D.
Stated limit: 0.1 mg/kg · LOQ

9. Betamethasone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 2 mg/kg · LOQ

10. Clobetasol propionate

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 1 mg/kg · LOQ

11. Cortisone acetate

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 1 mg/kg · LOQ

12. Dexamethasone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 2 mg/kg · LOQ

13. Dexamethasone phosphate

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 1 mg/kg · LOQ

14. Hydrocortisone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 1 mg/kg · LOQ

15. Methylprednisolone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 1 mg/kg · LOQ

16. Prednisolone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 2 mg/kg · LOQ

17. Prednisone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 2 mg/kg · LOQ

18. Triamcinolone

Method: LC/MS/MS; MOHW suggested cosmetic corticosteroid method

N.D.
Stated limit: 1 mg/kg · LOQ